Survival and patient-reported outcomes of real-world patients with high-risk stage II and stage III colon cancer after 3 versus 6 months of adjuvant CAPOX.

被引：0
|
作者：
Franken, Ingrid A.
van der Baan, Frederieke H.
Vink, Geraldine R.
May, Anne Maria
van Grevenstein, Wilhelmina M. U.
Koopman, Miriam
Roodhart, Jeanine
机构：
[1] Univ Med Ctr Utrecht, Dept Med Oncol, Utrecht, Netherlands
[2] Netherlands Comprehens Canc Org IKNL, Dept Res & Dev, Utrecht, Netherlands
[3] Julius Ctr Hlth Sci & Primary Care, Dept Epidemiol, Utrecht, Netherlands
[4] Univ Med Ctr Utrecht, Dept Surg Oncol, Utrecht, Netherlands
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3616
引用
收藏
页数：1
相关论文
共 50 条
  • [31] The efficacy of adjuvant chemotherapy for resected high-risk stage II and stage III colorectal cancer in frail patients
    Kosuke Mima
    Nobutomo Miyanari
    Keisuke Kosumi
    Takuya Tajiri
    Kosuke Kanemitsu
    Toru Takematsu
    Mitsuhiro Inoue
    Takao Mizumoto
    Tatsuo Kubota
    Hideo Baba
    International Journal of Clinical Oncology, 2021, 26 : 903 - 912
  • [32] The efficacy of adjuvant chemotherapy for resected high-risk stage II and stage III colorectal cancer in frail patients
    Mima, Kosuke
    Miyanari, Nobutomo
    Kosumi, Keisuke
    Tajiri, Takuya
    Kanemitsu, Kosuke
    Takematsu, Toru
    Inoue, Mitsuhiro
    Mizumoto, Takao
    Kubota, Tatsuo
    Baba, Hideo
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (05) : 903 - 912
  • [33] Association of NCCN guideline adherence with improved survival in high-risk stage II and stage III colon cancer.
    Boland, Genevieve Marie
    Chiang, Yj
    Chagpar, Ryaz
    Xing, Yan
    Hu, Chung-Yuan
    Feig, Barry W.
    Chang, George J.
    You, Y. Nancy
    Cormier, Janice N.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [34] Adjuvant chemotherapy improves survival in high-risk stage II colon cancer: a retrospective cohort study
    Liu, Lin-Lin
    Xiang, Zuo-Lin
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022, 15
  • [35] The hard road to patient-centered care: 3 or 6 months of adjuvant chemotherapy for patients with stage III colon cancer?
    Trensz, P.
    Calvel, L.
    Kurtz, J. E.
    ANNALS OF ONCOLOGY, 2018, 29 (07) : 1601 - 1601
  • [36] Adjuvant chemotherapy is not associated with improved survival for all high-risk factors in stage II colon cancer
    Verhoeff, S. R.
    van Erning, F. N.
    Lemmens, V. E. P. P.
    de Wilt, J. H. W.
    Pruijt, J. F. M.
    INTERNATIONAL JOURNAL OF CANCER, 2016, 139 (01) : 187 - 193
  • [37] High Expression of CUL9 Is Prognostic and Predictive for Adjuvant Chemotherapy in High-Risk Stage II and Stage III Colon Cancer
    Zheng, Peng
    Lv, Yang
    Mao, Yihao
    Shen, Feifan
    Zhang, Zhiyuan
    Chang, Jiang
    Yu, Shanchao
    Ji, Meiling
    Feng, Qingyang
    Xu, Jianmin
    CANCERS, 2022, 14 (16)
  • [38] Adjuvant Chemotherapy in High-risk Stage II Colon Cancer Patients: (Un) common Practice?
    Koebrugge, B.
    Van Steenbergen, L. N.
    Lips, D. J.
    Lemmens, V. E.
    Van der Linden, H. C.
    Pruijt, H. F.
    Liefers, G.
    Van de Velde, C. J.
    Bosscha, K.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S103 - S103
  • [39] Effect of adjuvant chemotherapy on survival benefit in stage III colon cancer patients stratified by age: a Japanese real-world cohort study
    Kawamura, Hidetaka
    Morishima, Toshitaka
    Sato, Akira
    Honda, Michitaka
    Miyashiro, Isao
    BMC CANCER, 2020, 20 (01)
  • [40] Effect of adjuvant chemotherapy on survival benefit in stage III colon cancer patients stratified by age: a Japanese real-world cohort study
    Hidetaka Kawamura
    Toshitaka Morishima
    Akira Sato
    Michitaka Honda
    Isao Miyashiro
    BMC Cancer, 20
12345